Latest Period
Q2 2026
Security Snapshot
Sagimet Biosciences Inc. - Common Stock Series A (SGMT) Institutional Ownership
CUSIP: 786700104
13F Institutional Holders and Ownership History from Q3 2023 to Q2 2026
Institutions Reporting
122
Shares (Excl. Options)
51,012,704
Price
$7.73
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock Series A
- Symbol
- SGMT on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 51,012,704
- Total 13F value
- $394,288,272
- Portfolio coverage rank
- 0%
- Share change
- +37,558,737
- Value change
- +$295,069,135
- Number of holders
- 122
- Shares outstanding
- 61,148,617
- SEC-reported price per share
- $7.45
- Insider filing price
- $7.45
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SGMT - Sagimet Biosciences Inc. - Common Stock Series A is tracked under CUSIP 786700104.
- 122 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 88 to 122 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $69,764,298 to $394,288,272.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 122 institutions filings for Q2 2026.
Security key
786700104
Latest holder period
Q2 2026
13F holders
122
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
SGMT full holder history
Sagimet Biosciences Inc. SEC filings
Sagimet Biosciences Inc. company facts
Sagimet Biosciences Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 786700104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
SGMT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 7.8% | $36,726,668 | 4,751,186 | BlackRock, Inc. | 30 Jun 2026 | |||
| BALYASNY ASSET MANAGEMENT L.P. | 5.9% | $26,978,281 | 3,626,113 | BALYASNY ASSET MANAGEMENT L.P. | 30 Jun 2026 | |||
| AP11 Ltd | 4.9% | -10% | $5,055,597 | -$504,198 | 1,504,642 | -9.1% | AP11 Limited | 24 Jun 2025 |
| Woodline Partners LP | 4.8% | -44% | $10,299,309 | -$7,211,088 | 1,501,357 | -41% | Woodline Partners LP | 30 Sep 2025 |
| Blue Owl Capital Holdings LP | 4.3% | $4,527,659 | 1,323,877 | Blue Owl Capital Holdings LP | 31 Dec 2024 |
As of 30 Jun 2026, 122 institutional investors reported holding 51,012,704 shares of Sagimet Biosciences Inc. - Common Stock Series A (SGMT). This represents 83% of the company’s total 61,148,617 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
71%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11% | 6,575,788 | +722% | 0% | $50,830,842 |
| Balyasny Asset Management L.P. | 5.9% | 3,626,113 | 0.05% | $28,029,853 | |
| Woodline Partners LP | 4.9% | 3,000,652 | +200% | 0.07% | $23,195,040 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 4.8% | 2,927,698 | 2.5% | $22,631,106 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 2,566,272 | +134% | 0% | $19,837,283 |
| Caligan Partners LP | 4.1% | 2,500,000 | 0.93% | $19,325,000 | |
| BVF INC/IL | 4.1% | 2,500,000 | 0.49% | $19,325,000 | |
| Affinity Asset Advisors, LLC | 4.1% | 2,497,864 | +188% | 0.94% | $19,308,489 |
| FEDERATED HERMES, INC. | 3.4% | 2,086,715 | +267085% | 0.02% | $16,130,307 |
| GREAT POINT PARTNERS LLC | 3.3% | 2,029,933 | 3.7% | $15,691,382 | |
| STATE STREET CORP | 3.3% | 1,995,092 | +1449% | 0% | $15,422,061 |
| Saturn V Capital Management LP | 2.4% | 1,479,918 | 1.6% | $11,439,766 | |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 1,444,019 | +367% | 0% | $11,165,095 |
| Blue Owl Capital Holdings LP | 2.1% | 1,260,544 | +278% | 1.5% | $9,744,005 |
| BAKER BROS. ADVISORS LP | 1.6% | 952,996 | 0% | 0.04% | $7,366,659 |
| MILLENNIUM MANAGEMENT LLC | 1.5% | 937,025 | +8.7% | 0% | $7,243,203 |
| Aberdeen Group plc | 1.4% | 847,700 | 0.01% | $6,552,721 | |
| GOLDMAN SACHS GROUP INC | 1.2% | 759,086 | +348% | 0% | $5,867,734 |
| HHLR ADVISORS, LTD. | 1.2% | 724,800 | 0% | 0.67% | $5,602,704 |
| AMERIPRISE FINANCIAL INC | 0.95% | 581,217 | 0% | $4,492,807 | |
| Vestal Point Capital, LP | 0.88% | 535,452 | 0.1% | $4,139,044 | |
| NORTHERN TRUST CORP | 0.77% | 468,385 | +744% | 0% | $3,620,617 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.76% | 464,095 | 0.07% | $3,587,454 | |
| ADAR1 Capital Management, LLC | 0.72% | 437,500 | 0.16% | $3,381,875 | |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 0.68% | 415,000 | 0.02% | $3,207,950 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
12
Latest
Q2 2026
Rows shown
1-12 of 12
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 51,012,704 | $394,288,272 | +$295,069,135 | $7.73 | 122 |
| 2026 Q1 | 13,353,997 | $69,764,298 | -$5,892,432 | $5.22 | 88 |
| 2025 Q4 | 14,395,244 | $85,220,750 | +$8,789,236 | $5.92 | 86 |
| 2025 Q3 | 12,635,689 | $86,680,189 | +$6,909,222 | $6.86 | 72 |
| 2025 Q2 | 11,676,267 | $88,988,335 | +$3,493,936 | $7.62 | 67 |
| 2025 Q1 | 13,776,513 | $44,920,783 | -$15,209,275 | $3.26 | 69 |
| 2024 Q4 | 17,500,774 | $78,763,978 | -$8,862,770 | $4.50 | 66 |
| 2024 Q3 | 19,656,790 | $54,446,688 | -$7,224,186 | $2.77 | 63 |
| 2024 Q2 | 20,925,200 | $71,568,836 | -$7,461,714 | $3.42 | 81 |
| 2024 Q1 | 22,609,183 | $122,544,913 | +$44,339,223 | $5.42 | 81 |
| 2023 Q4 | 14,445,035 | $76,118,157 | -$8,948,267 | $5.42 | 51 |
| 2023 Q3 | 11,717,467 | $103,113,019 | +$103,113,019 | $8.80 | 47 |